Omeros Analyst Price Targets - Benzinga

Omeros Corp

OMERNASDAQ

Trade with Public

Trade with Public

$17.49

1.207.37%

Dern. MÀJ: Oct 27, 7:58 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Omeros Analyst Price Targets - Benzinga

Omeros Analyst Price Targets

Wall Street analyst price targets and consensus rating for Omeros (OMER).

Price Target Range — 9 Quarters

Analyst Consensus — 6 Analysts

1S.Buy

4Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$26Upside to Avg. PT+48.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	Cantor Fitzgerald	Olivia Brayer Saunders	Maintained	Overweight	$22
Sep 22, 2026	Cantor Fitzgerald	Olivia Brayer Saunders	Upgrade	Neutral→Overweight	$22
Jun 26, 2026	HC Wainwright & Co.	Brandon Folkes	PT Cut	Buy	$40→$33
Jun 10, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$40
May 14, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$40
Apr 21, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Jan 27, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Jan 8, 2026	HC Wainwright & Co.	Brandon Folkes	PT Raise	Buy	$20→$40
Jan 8, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Dec 24, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Dec 1, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Nov 14, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Oct 16, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Oct 15, 2025	Needham	Serge Belanger	Maintained	Hold	—
Oct 15, 2025	WBB Securities	Steve Brozak	Maintained	Strong Buy	$45
Oct 15, 2025	HC Wainwright & Co.	Brandon Folkes	PT Raise	Buy	$9→$20
Oct 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Sep 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Aug 15, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$36
Aug 15, 2025	Needham	Serge Belanger	Maintained	Hold	—

Analyst Ratings News

PRO
Cantor Fitzgerald Reiterates Overweight on Omeros, Maintains $22 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates Omeros (NASDAQ:OMER) with a Overweight and maintains $22 price target.

Benzinga Newsdesk

This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday

Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.

Avi Kapoor

Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst

Cantor upgrades Omeros to Overweight with a $22 price forecast following strong Yartemlea sales and Medicare reimbursement momentum.

Vandana Singh

PRO
Cantor Fitzgerald Upgrades Omeros to Overweight, Announces $22 Price Target

Cantor Fitzgerald analyst Olivia Brayer Saunders upgrades Omeros (NASDAQ:OMER) from Neutral to Overweight and announces $22 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Omeros, Lowers Price Target to $33

HC Wainwright & Co. analyst Brandon Folkes maintains Omeros (NASDAQ:OMER) with a Buy and lowers the price target from $40 to $33.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $40 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Omeros (NASDAQ:OMER) with a Buy and maintains $40 price target.

Benzinga Newsdesk